| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848582 | American Journal of Kidney Diseases | 2013 | 13 Pages |
Abstract
In patients with CKD, higher ESA dose might be associated with all-cause mortality and cardiovascular complications independent of hemoglobin level.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ioannis MD, Mansour MD, Thomas A. MD, Ethan M. MD, MPH, Bertrand L. MD, MS,